Drp2 and periaxin form Cajal bands With dystroglycan but have distinct roles in Schwann cell growth

Journal of Neuroscience

Volumn 32, Issue 27, 2012, Pages 9419-9428

  Sherman, Diane L ^a   Wu, Lai Man N ^a   Grove, Matthew ^a   Stewart Gillespie, C ^a   Brophy, Peter J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DYSTROGLYCAN; DYSTROGLYCAN; DYSTROPHIN; DYSTROPHIN RELATED PROTEIN 2; NERVE PROTEIN; PERIAXIN; PROTEIN S 100; UNCLASSIFIED DRUG; UTROPHIN; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ELONGATION; COILED BODY; CONTROLLED STUDY; DEMYELINATION; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MORPHOMETRICS; MOUSE; NERVE CELL GROWTH; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; ROTAROD TEST; SCHWANN CELL; SCIATIC NERVE INJURY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; DYSTROGLYCANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; NERVE CRUSH; NERVE TISSUE PROTEINS; SCHWANN CELLS; SCIATIC NEUROPATHY;

EID: 84863422813     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1220-12.2012     Document Type: Article

References (59)

1. Abel A, Bone LJ, Messing A, Scherer SS, Fischbeck KH (1999) Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. J Neuropathol Exp Neurol 58:702-710.
2. Albrecht DE, Sherman DL, Brophy PJ, Froehner SC (2008) The ABCA1 cholesterol transporter associates with one of two distinct dystrophinbased scaffolds in Schwann cells. Glia 56:611-618.
3. Beynon RJ (1988) Prevention of unwanted proteolysis. Methods Mol Biol 3:1-23.
4. Birkedal-Hansen H, Taylor RE (1982) Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Commun 107:1173-1178.
5. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA (1993) Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250.
6. Boerkoel CF, Takashima H, Stankiewicz P, Garcia CA, Leber SM, Rhee-Morris L, Lupski JR (2001) Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 68:325-333.
7. Cohn RD, Campbell KP (2000) Molecular basis of muscular dystrophies. Muscle Nerve 23:1456-1471.
8. Colognato H, Winkelmann DA, Yurchenco PD (1999) Laminin polymerization induces a receptor-cytoskeleton network. J Cell Biol 145:619-631.
9. Court FA, Sherman DL, Pratt T, Garry EM, Ribchester RR, Cottrell DF, Fleetwood-Walker SM, Brophy PJ (2004) Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431:191-195.
10. Court FA, Hewitt JE, Davies K, Patton BL, Uncini A, Wrabetz L, Feltri ML (2009) A laminin-2, dystroglycan, utrophin axis is required for compartmentalization and elongation of myelin segments. J Neurosci 29:3908-3919.
11. Court FA, Zambroni D, Pavoni E, Colombelli C, Baragli C, Figlia G, Sorokin L, Ching W, Salzer JL, Wrabetz L, Feltri ML (2011) MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains. J Neurosci 31:12208-12217.
12. Deconinck AE, Potter AC, Tinsley JM, Wood SJ, Vater R, Young C, Metzinger L, Vincent A, Slater CR, Davies KE (1997) Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol 136:883-894.
13. Durbeej M, Larsson E, Ibraghimov-Beskrovnaya O, Roberds SL, Campbell KP, Ekblom P (1995) Non-muscle alpha-dystroglycan is involved in epithelial development. J Cell Biol 130:79-91.
14. Ervasti JM, Campbell KP (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122:809-823.
15. Gillespie CS, Sherman DL, Blair GE, Brophy PJ (1994) Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12:497-508.
16. Gillespie CS, Sherman DL, Fleetwood-Walker SM, Cottrell DF, Tait S, Garry EM, Wallace VC, Ure J, Griffiths IR, Smith A, Brophy PJ (2000) Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 26:523-531.
17. Grove M, Komiyama NH, Nave KA, Grant SG, Sherman DL, Brophy PJ (2007) FAK is required for axonal sorting by Schwann cells. J Cell Biol 176:277-282.
18. Guilbot A, Williams A, Ravisché N, Verny C, Brice A, Sherman DL, Brophy PJ, LeGuern E, Delague V, Bareil C, Mégarbané A, Claustres M (2001) A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 10:415-421.
19. Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, Michele DE, Muirhead DE, Kunz S, Moore SA, Iannaccone ST, Miyake K, McNeil PL, Mayer U, Oldstone MB, Faulkner JA, Campbell KP (2009) Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci U S A 106:12573-12579.
20. Hnia K, Hugon G, Masmoudi A, Mercier J, Rivier F, Mornet D (2006) Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane. Neuroscience 141:607-620.
21. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702.
22. Imamura M, Araishi K, Noguchi S, Ozawa E (2000) A sarcoglycandystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system. Hum Mol Genet 9:3091-3100.
23. Jeng LJ, Balice-Gordon RJ, Messing A, Fischbeck KH, Scherer SS (2006) The effects of a dominant connexin32 mutant in myelinating Schwann cells. Mol Cell Neurosci 32:283-298.
24. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
25. Li H, Mittal A, Makonchuk DY, Bhatnagar S, Kumar A (2009) Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum Mol Genet 18:2584-2598.
26. Li S, Edgar D, Fässler R, Wadsworth W, Yurchenco PD (2003) The role of laminin in embryonic cell polarization and tissue organization. Dev Cell 4:613-624.
27. Linderstrøm-Lang K, Møller KM (1953) Proteolytic enzymes. Annu Rev Biochem 22:57-84.
28. Masaki T, Matsumura K (2010) Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases. J Biomed Biotechnol 2010:740403.
29. Matsumura K, Yamada H, Shimizu T, Campbell KP (1993) Differential expression of dystrophin, utrophin and dystrophin-associated proteins in peripheral nerve. FEBS Lett 334:281-285.
30. Matsumura K, Zhong D, Saito F, Arai K, Adachi K, Kawai H, Higuchi I, Nishino I, Shimizu T (2005) Proteolysis of beta-dystroglycan in muscular diseases. Neuromuscul Disord 15:336-341.
31. Moghadaszadeh B, Albrechtsen R, Guo LT, Zaik M, Kawaguchi N, Borup RH, Kronqvist P, Schroder HD, Davies KE, Voit T, Nielsen FC, Engvall E, Wewer UM (2003) Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins. Hum Mol Genet 12:2467-2479.
32. Nageotte J (1910) Les étranglements de Ranvier et les espaces interannulaires des fibres nerveuses a myéline. Comptes Rendus de l'Association des Anatomistes 12:30-45.
33. Nemiloff A (1910) Über die Beziehung der sog. "Zellen der Schwannschen Scheide" zum Myelin in den Nervenfasen von Säugetieren. Archiv für Mikroskopische Anatomie und Entwicklungsgeschichte 76:329-348.
34. Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, Rosfa S, Kuharev J, Yan K, Bormuth I, Bremer J, Aguzzi A, Orfaniotou F, Hesse D, Schwab MH, Möbius W, Nave KA, Werner HB (2011) Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci 31:16369-16386.
35. Ramón y Cajal S (1912) El aparato endocelular de Golgi de la célula de Schwann y algunas observaciones sobre la estructura de los tubos nerviosos. Trabajos del Laboratorio de Investigaciones Biológicas de la Universidad de Madrid 10:221-246.
36. Ramón y Cajal S (1933) Histology. London: Bailliere, Tindall and Cox.
37. Reynolds JA, Tanford C (1970) Binding of dodecyl sulfate to proteins at high binding ratios. Possible implications for the state of proteins in biological membranes. Proc Natl Acad Sci U S A 66:1002-1007.
38. Saito F, Masaki T, Kamakura K, Anderson LV, Fujita S, Fukuta-Ohi H, Sunada Y, Shimizu T, Matsumura K (1999) Characterization of the transmembrane molecular architecture of the dystroglycan complex in schwann cells. J Biol Chem 274:8240-8246.
39. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Cohn RD, Williamson RA, Sluka KA, Sherman DL, Brophy PJ, Schmelzer JD, Low PA, Wrabetz L, Feltri ML, Campbell KP (2003) Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38:747-758.
40. Scherer SS, Xu YT, Bannerman PG, Sherman DL, Brophy PJ (1995) Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development. Development 121:4265-4273.
41. Scherer SS, Xu YT, Messing A, Willecke K, Fischbeck KH, Jeng LJ (2005) Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. J Neurosci 25:1550-1559.
42. Shang ZJ, Ethunandan M, Górecki DC, Brennan PA (2008) Aberrant expression of beta-dystroglycan may be due to processing by matrix metalloproteinases-2 and -9 in oral squamous cell carcinoma. Oral Oncol 44:113-1146.
43. Sherman DL, Brophy PJ (2000) A tripartite nuclear localization signal in the PDZ-domain protein L-periaxin. J Biol Chem 275:4537-4540.
44. Sherman DL, Fabrizi C, Gillespie CS, Brophy PJ (2001) Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 30:677-687.
45. Sherman DL, Tait S, Melrose S, Johnson R, Zonta B, Court FA, Macklin WB, Meek S, Smith AJ, Cottrell DF, Brophy PJ (2005) Neurofascins are required to establish axonal domains for saltatory conduction. Neuron 48:737-742.
46. Sherman DL, Krols M, Wu LM, Grove M, Nave KA, Gangloff YG, Brophy PJ (2012) Arrest of myelination and reduced axon growth when Schwann cells lack mTOR. J Neurosci 32:1817-1825.
47. Su H, Mills AA, Wang X, Bradley A (2002) A targeted X-linked CMV-Cre line. Genesis 32:187-188.
48. Tait S, Gunn-Moore F, Collinson JM, Huang J, Lubetzki C, Pedraza L, Sherman DL, Colman DR, Brophy PJ (2000) An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J Cell Biol 150:657-666.
49. Takashima H, Boerkoel CF, De Jonghe P, Ceuterick C, Martin JJ, Voit T, Schröder JM, Williams A, Brophy PJ, Timmerman V, Lupski JR (2002) Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol 51:709-715.
50. Tinsley JM, Blake DJ, Pearce M, Knight AE, Kendrick-Jones J, Davies KE (1993) Dystrophin and related proteins. Curr Opin Genet Dev 3:484-490.
51. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, Davies KE (1996) Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384:349-353.
52. Ushiki T, Ide C (1987) Scanning electron microscopic studies of the myelinated nerve fibres of the mouse sciatic nerve with special reference to the Schwann cell cytoplasmic network external to the myelin sheath. J Neurocytol 16:737-747.
53. Wallace HA, Marques-Kranc F, Richardson M, Luna-Crespo F, Sharpe JA, Hughes J, Wood WG, Higgs DR, Smith AJ (2007) Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence. Cell 128:197-209.
54. Williams AC, Brophy PJ (2002) The function of the Periaxin gene during nerve repair in a model of CMT4F. J Anat 200:323-330.
55. Yamada H, Shimizu T, Tanaka T, Campbell KP, Matsumura K (1994) Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett 352:49-53.
56. Yamada H, Saito F, Fukuta-Ohi H, Zhong D, Hase A, Arai K, Okuyama A, Maekawa R, Shimizu T, Matsumura K (2001) Processing of betadystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum Mol Genet 10:1563-1569.
57. Zaccaria ML, Di Tommaso F, Brancaccio A, Paggi P, Petrucci TC (2001) Dystroglycan distribution in adult mouse brain: a light and electron microscopy study. Neuroscience 104:311-324.
58. Zhong D, Saito F, Saito Y, Nakamura A, Shimizu T, Matsumura K (2006) Characterization of the protease activity that cleaves the extracellular domain of beta-dystroglycan. Biochem Biophys Res Commun 345:867-871.
59. Zonta B, Desmazieres A, Rinaldi A, Tait S, Sherman DL, Nolan MF, Brophy PJ (2011) A critical role for Neurofascin in regulating action potential initiation through maintenance of the axon initial segment. Neuron 69:945-956.